Joel M Henderson Selected Research

Thrombosis (Thrombus)

11/2017

Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joel M Henderson Research Topics

Disease

5	Proteinuria 01/2022 - 05/2012
3	Chronic Renal Insufficiency 06/2021 - 11/2017
3	Fibrosis (Cirrhosis) 06/2021 - 09/2013
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 06/2021 - 01/2010
2	Inflammation (Inflammations) 01/2021 - 07/2007
2	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2021 - 05/2016
2	Hypertension (High Blood Pressure) 01/2020 - 06/2004
2	Kidney Diseases (Kidney Disease) 10/2015 - 06/2004
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2022
1	Infections 06/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021
1	Hyperkalemia 01/2020
1	Immune System Diseases (Immune Disorders) 01/2020
1	Disease Progression 01/2018
1	Hemorrhage 11/2017
1	Thrombosis (Thrombus) 11/2017
1	Uremia 11/2017
1	Hypoalbuminemia 05/2016
1	Edema (Dropsy) 05/2016
1	Acute Kidney Injury (Acute Renal Failure) 10/2015
1	Sepsis (Septicemia) 02/2014
1	Multiple Abnormalities 03/2011
1	Lymphoma (Lymphomas) 04/2008
1	Neoplasms (Cancer) 04/2008
1	Glomerulonephritis 07/2007
1	Hyperparathyroidism 08/2004
1	Wounds and Injuries (Trauma) 08/2004
1	Thrombotic Microangiopathies 06/2004

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 06/2021 - 06/2004
3	AntibodiesIBA 01/2022 - 07/2007
3	AutoantibodiesIBA 01/2022 - 05/2016
2	CreatinineIBA 06/2021 - 03/2018
2	AlbuminsIBA 01/2021 - 05/2016
2	CollagenIBA 01/2018 - 05/2012
2	SaltsIBA 10/2015 - 08/2004
1	SteroidsIBA 01/2022
1	nephrinIBA 01/2022
1	PF-06730512IBA 06/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	Calcineurin InhibitorsIBA 01/2020
1	Thromboplastin (Tissue Factor)IBA 11/2017
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2017
1	Phospholipases (Phospholipase)IBA 05/2016
1	AutoantigensIBA 05/2016
1	Sodium Chloride FDA LinkGeneric 10/2015
1	corticosterone acetateIBA 10/2015
1	Cystatin CIBA 02/2014
1	phosphatidylserine receptorIBA 09/2013
1	Peptides (Polypeptides)IBA 09/2013
1	ForminsIBA 01/2010
1	Bcl-2-Like Protein 11IBA 04/2008
1	MicroRNAs (MicroRNA)IBA 04/2008
1	DNA (Deoxyribonucleic Acid)IBA 07/2007
1	Antigen-Antibody Complex (Immune Complex)IBA 07/2007
1	Immunoglobulins (Immunoglobulin)IBA 07/2007
1	Protein Tyrosine PhosphatasesIBA 07/2007
1	CalciumIBA 08/2004
1	Gemcitabine FDA Link 06/2004

Therapy/Procedure

2	Therapeutics 01/2022 - 11/2017
2	Organ Transplantation 06/2021 - 01/2020
1	Ligation 02/2014
1	Punctures 02/2014